A & T Respiratory Medicine

  Background  The mortality rate of community-acquired pneumonia (CAP) is high in adult patients. The highest mortality has been registered in patients in the older age group with a steady rise in the incidence of morbidity in younger people of working age.  There is a need to focus research on the role of neutrophils in the pathogenesis of pneumonia as CAP largely determines the outcomes of the same. This research is aimed at evaluating the indices of neutrophils oxidized-modified proteins and oxidative stress in patients with CAP, depending on the severity, and comparison of the frequency of neutrophil extracellular traps responsible for causing the progress of pneumonia.  Introduction The development of CAP is diverse among different patients. It is dependent on the etiology and the pathways of penetration of the microorganisms into the lungs.  The evaluation of the changes in the metabolic and functional status of neutrophils could be one of the urgent areas of research, as their

  CLICK HERE TO JOIN ME Lung and airway infections are commonly referred to as pulmonary or respiratory infections. Chronic bronchitis, COPD, influenza, tuberculosis, and pneumonia are some of the major forms of respiratory infections.  Nasopharyngeal infections that result in nasal discharge, bronchitis that leads to cough and sputum, and pneumonia that leads to cough with sputum can also increase the respiratory rate and lead to breathing difficulties.  There are several viruses that contribute to the increased incidence of bronchitis, while bacteria are known to contribute to pneumonia.  These infections usually spread from infected patients to healthy people through contaminated droplets released into the air when the infected person sneezes and coughs. These respiratory conditions are the leading causes of mortality and morbidity from infectious diseases across the world. Nearly four million people are estimated to die due to acute respiratory infection every year. About 98% of th

  Over the last few months, researchers have been working tirelessly to find out everything possible about SARS-CoV-2. And some of the facts they have learned are quite alarming.  Doctors no longer believe that once a person tests COVID negative after being treated for this infection, he is safe.  Research studies and clinical experience have shown that COVID-19 can create havoc in your body even after it has been treated or after you have recovered from the initial bout of illness. The infection tends to produce longer-lasting effects that may worsen or show up with variable intensity in the future.  Our ‘COVID19 PANDEMIC BY EXPERTS IN THE FIELD WEBINAR’ is focused on providing information about the latest developments in COVID-19 including the short-term and long-term complications this infection can cause. You can join this webinar to stay updated about the different ways COVID-19 can create havoc in the patient’s body.  While COVID-19 is widely known to affect the lungs, there is

COVID-19 Pandemic Treatments, Vaccinations, And Herd Immunit y   As the number of COVID-19 cases continues to rise across the world, everyone including patients, physicians, nurses, and healthcare workers are awaiting vaccines that might finally put an end to this challenging phase. There has also been a lot of discussion about herd immunity and how it would change the course of this pandemic. Most of us have our hopes pinned on herd immunity at least until vaccinations are made available. But what exactly is herd immunity and how it develops? Also, once we have it, will it really diminish the spread of this virus and reduce the need for social distancing and masks? These are the topmost questions in the minds of people. Let's find answers to what herb immunity actually means. What is herd immunity? Herd immunity is formed when enough patients have developed immunity to any specific infectious disease such that further community transmission is significantly reduced o

Management Of Respiratory Failure In COVID Patients It’s been more than 8 months now and still, the COVID-19 pandemic shows no sign of decline in the number of cases. What makes the COVID-19 pandemic a major cause of concern is the high risk of mortality associated with it, particularly due to respiratory failure. COVID-19 has a higher tropism for the lung and is known to cause severe pneumonia and ARDS (acute respiratory distress syndrome), especially in patients with a weak immune system and existing co-morbidities. This marks the need for the physicians, nurses, and healthcare workers to stay abreast of the latest information about the risk of ARDS and the recommended protocol for the management of respiratory distress in COVID-19 patients. Clinical features of ARDS in COVID-19 patents Most patients with COVID-induced respiratory distress meet the Berlin definition of ARDS. However, some patients may exhibit a different phenotype of ARDS with lower lung weight, higher lu